Exagon 400 mg/ml solution for injection
Exagon 400 mg/ml solution for injection
Autorizado
- Pentobarbital sodium
Identificação do produto
Nome do medicamento veterinário:
Exagon 400 mg/ml solution for injection
Exagon vet. 400 mg/ml injeksjonsvæske, oppløsning
Substância ativa:
- Disponível apenas em inglês
Espécies-alvo:
Via de administração:
-
Via intraperitoneal
-
Via intravenosa
-
Via intracardíaca
-
Via intrapulmonar
Detalhes do medicamento veterinário
Substância ativa e dosagem:
-
Disponível apenas em inglês400.00/miligrama(s)1.00mililitro(s)
Forma farmacêutica:
-
Solução injetável
Intervalo de segurança por via de administração:
-
Via intraperitoneal
-
Hare
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Rabbit
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
-
Via intravenosa
-
Pigeon
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
Eggno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Cattle
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
Milkno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Poultry
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
Eggno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Horse
-
Milkno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Horse (pony)
-
Milkno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Hare
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Rabbit
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Pig
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
-
Via intracardíaca
-
Hare
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Rabbit
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Pig
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
-
Via intrapulmonar
-
Pigeon
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
Eggno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Poultry
-
Meat and offalno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
Eggno withdrawal periodDo not use in animals intended for human or animal consumption. Adequate measures must be taken to ensure that carcasses of animals treated with this product and the by-products of these animals do not enter the food chain and are not used for human or animal consumption.
-
-
Código Anatomical Therapeutic Chemical Code (ATCvet):
- QN51AA01
Classificação quanto à dispensa:
-
Medicamento veterinário sujeito a prescrição veterinária
Estado da autorização:
-
Autorizado
Autorisado em:
-
Noruega
Disponibilidade:
-
Noruega
Informações adicionais
Titular da autorização de introdução no mercado:
- Vetviva Richter GmbH
Data de autorização de introdução no mercado:
Locais de fabrico para a libertação de lotes:
- Vetviva Richter GmbH
Autoridade responsável:
- Norwegian Medical Products Agency
Número da autorização:
- 13-9536
Data da alteração do estado de autorização:
Estado-Membro de referência:
-
Alemanha
Número de procedimento:
- DE/V/0155/001
Estados-Membros envolvidos:
-
Áustria
-
República Checa
-
Dinamarca
-
Estónia
-
Finlândia
-
França
-
Grécia
-
Islândia
-
Itália
-
Letónia
-
Lituânia
-
Noruega
-
Polónia
-
Portugal
-
Roménia
-
Eslováquia
-
Eslovénia
-
Espanha
-
Suécia
Para consultar as notificações de suspeitas de eventos adversos: www.adrreports.eu/vet
Documentos
Resumo das características do medicamento
Este documento não existe neste idioma (português). Você pode encontrá -lo em outro idioma abaixo.
Norwegian (PDF)
Publicado em: 18/04/2023
inglês (PDF)
Publicado em: 18/04/2023
Folheto informativo
Este documento não existe neste idioma (português). Você pode encontrá -lo em outro idioma abaixo.
Norwegian (PDF)
Publicado em: 6/06/2023
Combined File of all Documents
Este documento não existe neste idioma (português). Você pode encontrá -lo em outro idioma abaixo.
inglês (PDF)
Publicado em: 5/06/2023
